✦ LIBER ✦

Crystal Structure of Human Carbonyl Reductase 1 Implications for Structure Based Drug Design

✍ Scribed by Rauh, D.

Book ID: 119277100
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 170 KB
Volume: 117
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2005.12.569

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structures of Trihydroxynaphthalene Redu

Structures of Trihydroxynaphthalene Reductase-Fungicide Complexes: Implications for Structure-Based Design and Catalysis

✍ Der-Ing Liao; Gregory S. Basarab; Anthony A. Gatenby; Barbara Valent; Douglas B. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 750 KB

[Methods in Molecular Biology] Structure

[Methods in Molecular Biology] Structure-Based Drug Discovery Volume 841 || Protein Crystallization for Structure-Based Drug Design

✍ Tari, Leslie W. 📂 Article 📅 2011 🏛 Humana Press ⚖ 505 KB

How Reliable Are Current Docking Approac

How Reliable Are Current Docking Approaches for Structure-Based Drug Design? Lessons from Aldose Reductase

✍ Matthias Zentgraf; Holger Steuber; Cornelia Koch; Concettina La Motta; Stefania 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 3 views

Stable isotope labelling of human histam

Stable isotope labelling of human histamine receptor H1R: Prospects for structure-based drug design

✍ T. A. Egorova-Zachernyuk; G. J. C. G. M. Bosman; W. J. DeGrip; V. I. Shvets 📂 Article 📅 2010 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 164 KB

CD4 dimerization and oligomerization: im

CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design

✍ Song Li; Takashi Satoh; Robert Korngold; Ziwei Huang 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 946 KB

Recent studies of CD4 structure and function have revealed possible mechanisms for CD4 self-association, with implications for its role in T-cell activation. Here, the authors discuss the formulation of a hypothetical three-dimensional model of CD4 oligomerization and how it impacts on the understan

Structure-based drug design of nonpeptid

Structure-based drug design of nonpeptidic P2 substituents for HIV-1 protease inhibitors

✍ Vincent J. Kalish; John H. Tatlock; Jay F. Davies II; Stephen W. Kaldor; Bruce A 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 290 KB

The cocrystal structures of LY289612 and LY297135 were used as a starting point in the design of nonpeptidic HIV-1 protease inhibitors. This report details the discovery of a series of novel aromatic P2 replacement groups. The 3-hydroxy-2-methyl benzoic acid group, discovered in AG1254, was incorpor